Discover Absci Corporation's Q1 2025 earnings highlights: clinical trial milestones, AI-driven biotech innovation, and strong financial outlook.

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost ...

The genome structure—how genes are organized within DNA sequences in an organism—is fundamental to the processes and ...

These companies are fighting for a cut of the billions upon billions people spend annually in pursuit of gut peace.

Probiotics may help with many health conditions. Although they're generally safe, it's important to talk with your doctor ...

Scientists led by Karla Satchell, Ph.D., the Anne Stewart Youmans Professor of Microbiology at Northwestern University, have ...

Xichem AB (publ), (aXichem), the developer of innovative feed additives and food supplement ingredients, announces that the Company, after very successful tests at a major chicken meat production faci ...

Try our new Search AI tool as an alternative to the search below to improve your experience on Alberta.ca using artificial intelligence. See the AISearch fact sheet for more information.